Clik here to view.
Medtronic’s Ev3 wins 2nd appeal in ex-rep’s whistleblower lawsuit
A federal appeals court last week dismissed a whistleblower lawsuit filed by a former sales rep for Medtronic (NYSE:MDT) subsidiary Ev3, ruling that the allegations weren’t strong enough to sustain a...
View ArticleClik here to view.
Minerva Surgical raises $16.7m for Aurora endometrial ablation device
Minerva Surgical reported a funding round worth $16.7 million and said it wants to raise $10 million more. Redwood City, Calif.-based Minerva, founded in 2008, is developing technologies for treatment...
View ArticleClik here to view.
Appeals court resuscitates Infuse lawsuit against Medtronic
A federal appeals court yesterday resuscitated a shareholders lawsuit accusing Medtronic (NYSE:MDT) of concealing for nearly 10 years the negative side effects of its Infuse bone growth protein. The...
View ArticleClik here to view.
Gates Foundation puts $140m into $206m round for Intarcia
Intarcia Therapeutics said today that it raised a $206m Series EE round and inked a deal with the Bill & Melinda Gates Foundation to fight HIV in emerging nations. It’s the 2nd of 3 tranches in an...
View ArticleClik here to view.
Alere sues CMS to reinstate its Arriva diabetes unit
Alere (NYSE:ALR) yesterday said that it’s suing to force the Centers for Medicare & Medicaid Services to reinstate its Arriva diabetes division’s enrollment, after the government health insurer...
View ArticleClik here to view.
Japan approves market return for NuVasive’s XLIF spinal fusion
NuVasive Inc. (NSDQ:NUVA) said today that it won approval from the Japanese Ministry of Health, Labor & Welfare for the return of instruments used in its eXtreme lateral interbody fusion procedure...
View ArticleClik here to view.
Femasys raises $40m Series C for FemBloc permanent female contraception device
Femasys said earlier this month that it closed on a Series C round worth $40 million it plans to use on a pivotal trial of its FemBloc permanent female contraception device now that it has FDA approval...
View ArticleClik here to view.
MassDevice.com +5 | The top 5 medtech stories for December 29, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View ArticleClik here to view.
The future of cardiac MRI: 3D cine
The heart is a dynamic, beating organ, and until now it has been challenging to fully capture its complexity by magnetic resonance imaging (MRI). In an ideal world, doctors could create a 3-D visual...
View ArticleClik here to view.
Abbott’s $25B St. Jude Medical tie-up approved in China
Anti-trust regulators in China today granted conditional approval to the $25 billion tie-up of Abbott (NYSE:ABT) and St. Jude Medical (NYSE:STJ). China’s Ministry of Commerce said the approval is...
View ArticleClik here to view.
Provectus axes CEO Culpepper for expense account violations
Provectus Biopharmaceuticals Inc. (OTCQB:PVCT) said this week that its board of directors voted unanimously to terminate CEO and chief operating officer Peter Culpepper, after an internal investigation...
View ArticleClik here to view.
Apollo Endosurgery, Lpath close reverse merger
Apollo Endosurgery and Lpath (NSDQ:LPTN) said yesterday that they closed a reverse merger in which Apollo put another $29 million into the combined company. Shares in the new company, which will adopt...
View ArticleClik here to view.
Stealthy NeuroVasc Technologies raises $1m
Stealthy NeuroVasc Technologies said yesterday that it raised a $1 million funding round, taking it’s total raise since last year to nearly $2.5 million. Laguna Hills, Calif.-based NeuroVasc is led by...
View ArticleClik here to view.
FDA rejects Amphastar subsidiary’s Primatene Mist asthma inhaler
Amphastar Pharmaceuticals (NSDQ:AMPH) said this week that the FDA denied its subsidiary’s new drug application for the latest version of its Primatene Mist epinephrine inhaler. The complete response...
View ArticleClik here to view.
Nikon’s Optos, Google’s Verily ink deal for machine learning in retinal imaging
Nikon (TYO:7731) subsidiary Optos and Google (NSDQ:GOOG) unit Verily inked a deal this week to develop technologies for machine learning-enabled retinal imaging. The deal calls for the companies will...
View ArticleClik here to view.
BioCardia launches pivotal trial for CardiAmp heart failure treatment
BioCardia (NSDQ:BCDA) initiated its CardiAmp pivotal trial this week to evaluate its cell therapy at 40 clinical sites across the U.S. The pivotal trial is a part of the company’s efforts for premarket...
View ArticleClik here to view.
Humacyte launches Phase II trial for artificial bypass graft in PAD
Humacyte said yesterday that it started a phase II trial of its human acellular vessel, Humacyl, as an artificial bypass graft in patients with peripheral arterial disease. The non-randomized trial is...
View ArticleClik here to view.
Abbott to close $25B St. Jude buy
Abbott (NYSE:ABT) said today that it plans to close its $25 billion buy of St. Jude Medical (NYSE:STJ) next Wednesday, Jan. 4, after receiving all necessary regulatory clearances for the deal. Abbott...
View ArticleClik here to view.
Neurelis closes Series B for intranasal diazepam spray
Neurelis, Inc. said today that it closed a Series B financing round, led by HBM Healthcare Investments. Other investors included LYZZ Capital, which previously led a Series A funding round for the...
View ArticleClik here to view.
AirXpander’s AeroForm tissue expander transforms decades-old procedure
For 40 years, plastic surgeons have used saline injections to expand tissue and prepare patients for breast implants following mastectomies. These tissue expanders consist of a silicone shell with a...
View Article